Abstract
Oral squamous cell carcinoma (OSCC) is one of the most common cancers worldwide. MicroRNAs (miRNAs) are small noncoding RNAs that post-transcriptionally modulate gene expression by degrading or repressing the translation of target messenger RNAs (mRNA). Aberrant miRNA expression has been reported in OSCC, and this altered expression may be useful for the early detection of oral cancer. In this review we highlight the miRNAs profile of OSCC, the possible mechanisms underlying their altered expression together with their function in oral cancer development and progression. The modulation of miRNAs makes these small molecules potential markers for early oral cancer diagnosis and prognostic prediction as well as potential molecular tools for its treatment. Translational studies focusing on miRNAs could lead to the development of new tools for the management of patients with OSCC.
Keywords: Oral squamous cell carcinoma, microRNAs, miRNAs, biomarkers, oral cancer, gene expression, translation, messenger RNAs (mRNA), cancer development, progression
Current Pharmaceutical Design
Title:microRNAs: Small Molecules with a Potentially Role in Oral Squamous Cell Carcinoma
Volume: 19 Issue: 7
Author(s): Carolina Cavalieri Gomes, Silvia Ferreira de Sousa and Ricardo Santiago Gomez
Affiliation:
Keywords: Oral squamous cell carcinoma, microRNAs, miRNAs, biomarkers, oral cancer, gene expression, translation, messenger RNAs (mRNA), cancer development, progression
Abstract: Oral squamous cell carcinoma (OSCC) is one of the most common cancers worldwide. MicroRNAs (miRNAs) are small noncoding RNAs that post-transcriptionally modulate gene expression by degrading or repressing the translation of target messenger RNAs (mRNA). Aberrant miRNA expression has been reported in OSCC, and this altered expression may be useful for the early detection of oral cancer. In this review we highlight the miRNAs profile of OSCC, the possible mechanisms underlying their altered expression together with their function in oral cancer development and progression. The modulation of miRNAs makes these small molecules potential markers for early oral cancer diagnosis and prognostic prediction as well as potential molecular tools for its treatment. Translational studies focusing on miRNAs could lead to the development of new tools for the management of patients with OSCC.
Export Options
About this article
Cite this article as:
Cavalieri Gomes Carolina, Ferreira de Sousa Silvia and Santiago Gomez Ricardo, microRNAs: Small Molecules with a Potentially Role in Oral Squamous Cell Carcinoma, Current Pharmaceutical Design 2013; 19 (7) . https://dx.doi.org/10.2174/138161213804805694
DOI https://dx.doi.org/10.2174/138161213804805694 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genetic and Epigenetic Regulation of Phosphoinositide 3-kinase Isoforms
Current Pharmaceutical Design The Ubiquitin-Proteasome System as a Prospective Molecular Target for Cancer Treatment and Prevention
Current Protein & Peptide Science FAK and Nanog Cross Talk with p53 in Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Long Non-Coding RNAs As Epigenetic Regulators in Cancer
Current Pharmaceutical Design Imaging Requirements for Personalized Medicine: The Oncologists Point of View
Current Pharmaceutical Design Actinic Keratosis: Review of the Literature and New Patents
Recent Patents on Inflammation & Allergy Drug Discovery The PI3 Kinase Signaling Pathway in Prostate Cancer
Current Cancer Drug Targets HER3 and its Ligand, Heregulin, as Targets for Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Pharmacogenomics of Cytochrome P450 Enzymes in Tumours
Current Pharmacogenomics In Silico Modeling for the Design of 2-substitted Benzimidazole Derivatives, and Prediction of Activity as Procaspase-3 Activators and Apoptosis Inducer
Letters in Drug Design & Discovery The Chemopreventive Peptide Lunasin Inhibits d-Galactose- Induced Experimental Cataract in Rats
Protein & Peptide Letters EGFR(s) in Aging and Carcinogenesis of the Gastrointestinal Tract
Current Protein & Peptide Science The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry The Fluctuations of Melatonin and Copeptin Levels in Blood Serum During Surgical Stress Regarding the Pediatric Population
Current Pediatric Reviews Activities of Venom Proteins and Peptides with Possible Therapeutic Applications from Bees and WASPS
Protein & Peptide Letters HMGB1-Directed Drug Discovery Targeting Cutaneous Inflammatory Dysregulation
Current Drug Metabolism Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins
Current Cancer Drug Targets Epigenome-Wide Association Studies (EWAS) in Cancer
Current Genomics Garlic (<i>Allium sativum</i> L.): Its Chemistry, Nutritional Composition, Toxicity, and Anticancer Properties
Current Topics in Medicinal Chemistry Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
Current Cancer Drug Targets